Published in Diabetes Metab on April 01, 2003
Diagnosing gestational diabetes. Diabetologia (2011) 3.34
Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health (2005) 2.45
Prevalence of gestational diabetes mellitus & associated risk factors at a tertiary care hospital in Haryana. Indian J Med Res (2013) 1.80
Balancing weight and glucose in gestational diabetes mellitus. Diabetes Care (2013) 1.54
The prevalence of metabolic syndrome among US women of childbearing age. Am J Public Health (2008) 1.15
Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol (2012) 0.99
The independent effects of maternal obesity and gestational diabetes on the pregnancy outcomes. BMC Endocr Disord (2014) 0.97
Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta-analysis. Biomed Res Int (2014) 0.95
Diabetes is associated with impairment of uterine contractility and high Caesarean section rate. Diabetologia (2011) 0.85
Race/ethnicity disparities in dysglycemia among U.S. women of childbearing age found mainly in the nonoverweight/nonobese. Diabetes Care (2013) 0.81
The independent effects of second hand smoke exposure and maternal body mass index on the anthropometric measurements of the newborn. BMC Public Health (2013) 0.79
Waist-to-Hip Ratio versus Body Mass Index as Predictor of Obesity-Related Pregnancy Outcomes. Am J Perinatol (2016) 0.77
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Why are clinical laboratory tests performed? When are they valid? JAMA (1975) 2.66
Decreased globin messenger RNA in thalassemia detected by molecular hybridization. Proc Natl Acad Sci U S A (1973) 2.07
Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia (2007) 2.01
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia (2012) 1.98
Abnormal or absent beta mRNA in betao Ferrara and gene deletion in delta beta thalassaemia. Nature (1976) 1.96
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67
Idiopathic coccygodynia. Analysis of fifty-one operative cases and a radiographic study of the normal coccyx. J Bone Joint Surg Am (1983) 1.66
Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev (1998) 1.57
Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest (1999) 1.47
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest (2001) 1.40
Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes. Diabete Metab (1994) 1.39
[A case of prolonged QT syndrome]. Rev Esp Anestesiol Reanim (1994) 1.37
Dietary fat and gestational hyperglycaemia. Diabetologia (2001) 1.36
Changes in globin messenger RNA content during erythroid cell differentiation. J Biol Chem (1975) 1.32
Nucleotide sequence analysis of RNA synthesized from rabbit globin complementary DNA. Proc Natl Acad Sci U S A (1974) 1.31
Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev (2009) 1.26
Maternal vascular prostacyclin activity in pre-eclampsia. Lancet (1980) 1.24
A limited number of globin genes in human DNA. Proc Natl Acad Sci U S A (1974) 1.23
Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR. Assessment on 18,000 consecutive clinical samples. Mol Hum Reprod (2004) 1.20
An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest (1983) 1.20
Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev (2013) 1.14
Should we consider gestational diabetes a vascular risk factor? Atherosclerosis (2006) 1.14
Polyadenylate sequences and biologic activity of human globin messenger ribonucleic acid. J Biol Chem (1974) 1.11
The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis (1999) 1.09
Cyclic adenosine monophosphate-dependent phosphorylation of mammalian mitochondrial proteins: enzyme and substrate characterization and functional role. Biochemistry (2001) 1.08
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer (2001) 1.07
Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest (1985) 1.05
In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis (1995) 1.05
Diagnosis of acute myocardial infarction. Relative efficiency of serum enzyme and isoenzyme measurements. JAMA (1975) 1.05
Genetic and physical mapping of new EST-derived SSRs on the A and B genome chromosomes of wheat. Theor Appl Genet (2009) 1.05
A provocative maneuver to elicit cystometric instability: measuring instability at maximum infusion. J Urol (1999) 1.04
Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis. J Endocrinol Invest (1992) 1.04
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol (2005) 1.02
Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond) (2005) 1.02
Morphologic changes in annulus fibrosus during aging. An ultrastructural study in rats. Spine (Phila Pa 1976) (1984) 1.02
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration. Oncogene (2012) 1.01
Relevance of prostaglandins in true menstrual migraine. Headache (1989) 1.01
Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Invest (2004) 1.01
Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia (1999) 1.01
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res (2001) 1.00
Dextrose infusion by artificial pancreas in diagnosis of insulinoma. Lancet (1982) 1.00
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study. Diabetologia (2006) 1.00
Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care (1996) 1.00
National diabetes programs. Application of capture-recapture to count diabetes? Diabetes Care (1994) 1.00
C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest (2005) 1.00
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia (2005) 0.99
Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort. Spinal Cord (1999) 0.98
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin Cancer Res (1999) 0.97
Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun (2000) 0.97
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem (2013) 0.96
Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer. Gynecol Oncol (2004) 0.96
Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids (2001) 0.95
Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure. Br J Pharmacol (2012) 0.95
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. Int J Obes (Lond) (2011) 0.95
Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection. Clin Ther (2000) 0.95
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer (2002) 0.95
Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Ann N Y Acad Sci (1999) 0.95
Increasing trend of type I diabetes in children and young adults in the province of Turin (Italy). Analysis of age, period and birth cohort effects from 1984 to 1996. Diabetologia (2001) 0.94
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res (2001) 0.94
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics. Arch Intern Med (1987) 0.94
Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metastasis Rev (1999) 0.94
Low socioeconomic status as a risk factor for gestational diabetes. Diabetes Metab (2002) 0.94
Influence of a familial history of diabetes on the clinical characteristics of patients with Type 2 diabetes mellitus. Diabet Med (2000) 0.94